23 February 2021 | News
This collaboration will allow opportunities to support future initiatives such as medical education through the IDF School of Diabetes
Source credit: Shutterstock
Gan & Lee Pharmaceuticals Co, Ltd, a global biopharmaceutical company based in China, has announced a collaborative partnership with the International Diabetes Federation (IDF) that aims to support their global efforts of promoting diabetes care and prevention worldwide.
This collaboration will allow opportunities to support future initiatives such as medical education through the IDF School of Diabetes as well as becoming inaugural partners in the launch of the IDF WeChat platform in China.
This partnership will also provide the opportunity to participate in advocacy initiatives such as World Diabetes Day and the Centenary of Insulin.
"Gan & Lee's collaboration with IDF will provide an opportunity to support global outreach and advocacy initiatives to help improve the lives of people affected by diabetes," said Kai Du, CEO, Gan & Lee Pharmaceuticals, Chairman, Gan & Lee USA Corporation.
"The International Diabetes Federation is delighted to welcome Gan & Lee as a partner to support our global awareness, advocacy and education initiatives. In a year that marks the centenary of the discovery of insulin, coordinated and collaborative action to ensure affordable and uninterrupted care and education for every person living with diabetes, regardless of where they live or their economic circumstances, is more important than ever," said Prof Andrew Boulton, President, International Diabetes Federation.